Alzamend Neuro Inc. (NASDAQ:ALZN) went down by -5.76% from its latest closing price compared to the recent 1-year high of $33.55. The company’s stock price has collected -11.18% of loss in the last five trading sessions. Press Release reported 18 hours ago that Alzamend Neuro Announces Initiation of Phase I First-in-Human Clinical Trial for AL001 for Dementia Related to Alzheimer’s Disease
Is It Worth Investing in Alzamend Neuro Inc. (NASDAQ :ALZN) Right Now?
Opinions of the stock are interesting as 0 analysts out of 0 who provided ratings for Alzamend Neuro Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 0 rated it as “hold,” and 0 as “sell.”
ALZN currently public float of 43.34M and currently shorts hold a 1.20% ratio of that float. Today, the average trading volume of ALZN was 2.30M shares.
ALZN’s Market Performance
The volatility ratio for the week stands at 8.28% while the volatility levels for the past 30 days are set at 8.65% for Alzamend Neuro Inc.. The simple moving average for the period of the last 20 days is -12.34% for ALZN stocks with a simple moving average of -49.23% for the last 200 days.
ALZN Trading at -38.17% from the 50-Day Moving Average
After a stumble in the market that brought ALZN to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -91.71% of loss for the given period.
Volatility was left at 8.65%, however, over the last 30 days, the volatility rate increased by 8.28%, as shares sank -20.11% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -63.80% lower at present.
During the last 5 trading sessions, ALZN fell by -11.18%, in comparison to the 20-day moving average, which settled at $3.14. In addition, Alzamend Neuro Inc. saw -79.41% in overturn over a single year, with a tendency to cut further losses.
Reports are indicating that there were more than several insider trading activities at ALZN starting from AULT MILTON C III, who purchase 6,000 shares at the price of $2.90 back on Aug 27. After this action, AULT MILTON C III now owns 6,715,388 shares of Alzamend Neuro Inc., valued at $17,430 using the latest closing price.
AULT MILTON C III, the 10% Owner of Alzamend Neuro Inc., purchase 4,000 shares at $3.29 during a trade that took place back on Aug 17, which means that AULT MILTON C III is holding 6,709,388 shares at $13,170 based on the most recent closing price.
Stock Fundamentals for ALZN
The total capital return value is set at -312.43, while invested capital returns managed to touch -356.06.
Based on Alzamend Neuro Inc. (ALZN), the company’s capital structure generated 16.66 points at debt to equity in total, while total debt to capital is 14.28.
The liquidity ratio also appears to be rather interesting for investors as it stands at 2.85.